Induced abortions in women with systemic lupus erythematosus.

Abstract:

OBJECTIVES:To determine the rates of induced abortions in women with systemic lupus erythematosus (SLE) compared to women from the general population and assess disease-related predictors of induced abortion in women with SLE. METHODS:We identified women with SLE (15-45 years) and determined the number of induced abortions, using Quebec's administrative databases. We calculated the standardized incidence ratio (SIR) using general population rates. We also performed a nested-case control analysis to investigate predictors of induced abortions in SLE women (such as teratogenic immunosuppressive and corticosteroid exposures). RESULTS:Among 2508 women with SLE, we observed 293 induced abortions [incidence rate of 17.1 induced abortions per 1000 person-years (95% CI 15.2, 19.2)]. There was no clear difference in the number of induced abortions among women with SLE versus women from the general population (SIR 1.10; 95% CI 0.98, 1.24). In the multivariable analysis, we did not observe higher rates of induced abortions among women exposed to teratogenic immunosuppressives [rate ratio (RR) 0.37; 95% CI 0.13, 1.07] or using corticosteroids (RR 0.67; 95% CI 0.39, 1.16). CONCLUSION:Our findings suggest that women with SLE have a similar rate of induced abortions as compared to the general population. This raises some concerns as unplanned pregnancies in SLE women can lead to adverse maternal and fetal outcomes. Our results should prompt further research on family planning counselling in women with SLE.

journal_name

Lupus

journal_title

Lupus

authors

Venne K,Scott S,Bernatsky S,Vinet E

doi

10.1177/0961203320979741

subject

Has Abstract

pub_date

2020-12-15 00:00:00

pages

961203320979741

eissn

0961-2033

issn

1477-0962

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.

    abstract::The purpose of study was to determine the nature, outcomes and associated risk factors of invasive fungal infection (IFI) in patients with systemic lupus erythematosus (SLE), and compare the incidence of IFI in patients with rheumatoid arthritis (RA). A total of 1155 patients with SLE and 2004 patients with RA were re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309103081

    authors: Kim HJ,Park YJ,Kim WU,Park SH,Cho CS

    更新日期:2009-06-01 00:00:00

  • Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.

    abstract::We have explored the relationship between possible hemostatic changes and clinical manifestation of the systemic lupus erythematosus (SLE) as a function of greater or lesser disease activity according to Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) criteria. Endothelial injury and hypercoagulab...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319899478

    authors: Cicarini WB,Duarte RCF,Ferreira KS,Loures CMG,Consoli RV,Neiva CLS,de Pádua PM,Nunes FFC,Alves LCV,Reis EA,Moreira CC,Guimarães TMPD,de Toledo VPCP,Carvalho MDG

    更新日期:2020-02-01 00:00:00

  • Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety.

    abstract::Concerns regarding the safety and efficacy of immunization in patients with SLE have persisted for over 60 years, despite the increased risk of infection in these patients. There are many anecdotal case reports of SLE induction or exacerbation following immunization, but overall, these events seem to be very rare. Evi...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203306069355

    authors: O'Neill SG,Isenberg DA

    更新日期:2006-01-01 00:00:00

  • Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures.

    abstract::Antiphospholipid syndrome (APS) is an autoimmune disease characterized by recurrent thrombotic events, miscarriages and thrombocytopenia with persistently positive antiphospholipid antibodies.( 1,2 ) APS may be isolated (primary APS) or associated to a connective tissue disease, most often systemic lupus erythematosus...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311405373

    authors: Taipa R,Santos E

    更新日期:2011-11-01 00:00:00

  • Antiphospholipid syndrome induced by HIV.

    abstract::A 24-y-old male who developed necrotic lesions on the lower extremities together with testicular thrombosis necessitating orchiectomy, demonstrated high level IgG anticardiolipin (aCL) associated with acute HIV infection. This is one of the first cases describing a close relationship between viral infection and the cl...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301669209574

    authors: Leder AN,Flansbaum B,Zandman-Goddard G,Asherson R,Shoenfeld Y

    更新日期:2001-01-01 00:00:00

  • Protein S deficiency revealed by skin necrosis in a patient with lupus.

    abstract::Protein S deficiency is rare in systemic lupus erythematosus (SLE) and is generally associated with the presence of antiphospholipid (APL) antibodies. Lack of protein S can cause skin necrosis, but when it does it is generally in response to warfarin exposure. In this article, we describe the case of a patient who had...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319843345

    authors: Plana-Pla A,Bielsa Marsol I,Ferrandiz Foraster C

    更新日期:2019-06-01 00:00:00

  • Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study.

    abstract::Controversy exists concerning the prevalence of headache in systemic lupus erythematosus (SLE) and its importance as a neuropsychiatric manifestation, especially when it occurs independently of disease activity and with the typical characteristics of primary chronic headache. Most reports to date have either studied b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847443

    authors: Fernández-Nebro A,Palacios-Muñoz R,Gordillo J,Abarca-Costalago M,De Haro-Liger M,Rodríguez-Andreu J,González-Santos P

    更新日期:1999-01-01 00:00:00

  • Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

    abstract::To determine whether killer cell immunologlobulin-like receptor (KIR) genotypes are associated with vasculitis, vascular arterial events or anticardiolipin (aCL) antibodies in patients with lupus. A total of 304 patients followed prospectively at the University of Toronto Lupus Clinic were assessed for the occurrence ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089443

    authors: Toloza S,Pellett F,Chandran V,Ibanez D,Urowitz M,Gladman D

    更新日期:2008-09-01 00:00:00

  • Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus.

    abstract::Leukopenia and anaemia are observed in about a fifth of all patients with systemic lupus erythematosus (SLE) and may be due either to the destruction of blood cells or their decreased production. The former may be humoral or cell-mediated or result from apoptosis of peripheral blood cells. Several observations suggest...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu423oa

    authors: Tiefenthaler M,Bacher N,Linert H,Mühlmann O,Hofer S,Sepp N,Amberger A,Geisen F,Obermoser G,Konwalinka G

    更新日期:2003-01-01 00:00:00

  • Antiphospholipid antibodies and myocardial infarction.

    abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700229

    authors: Vaarala O

    更新日期:1998-01-01 00:00:00

  • Pulmonary arterial hypertension in SLE: what do we know?

    abstract::Pulmonary hypertension (PH) can occur at any time during the course of systemic lupus erythematosus (SLE), and can be independent of lupus disease activity in other systems. The pathogenesis of PH in SLE can be multifactorial, but pulmonary arterial hypertension (PAH) is the commonest cause of PH in SLE. The internati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313505010

    authors: Prabu A,Gordon C

    更新日期:2013-10-01 00:00:00

  • The illness experience of youth with lupus/mixed connective tissue disease: a mixed methods analysis of patient and parent perspectives.

    abstract:OBJECTIVE:We aimed to develop a model of the illness experience for youth with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD). METHODS:We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, age 11 to 22 years, and their parents. We qualitatively defined key featur...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316646460

    authors: Knight A,Vickery M,Fiks AG,Barg FK

    更新日期:2016-08-01 00:00:00

  • Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study.

    abstract::Multiple sources were used to identify 325 systemic lupus erythematosus (SLE) patients within the city of Oslo during 1999-2009 who met ≥ 4 of the American College of Rheumatology (ACR) criteria. The survival, standard mortality rate (SMR), years of potential life loss before 60 years of age (YPLL60) and causes of dea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314551083

    authors: Lerang K,Gilboe IM,Steinar Thelle D,Gran JT

    更新日期:2014-12-01 00:00:00

  • High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is an immune-mediated disease that is responsive to suppression or modulation of the immune system. Patients with SLE who experience persistent multiorgan dysfunction, despite standard doses of intravenous cyclophosphamide (Cy), represent a subset of patients at high risk of early de...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu491oa

    authors: Lisukov IA,Sizikova SA,Kulagin AD,Kruchkova IV,Gilevich AV,Konenkova LP,Zonova EV,Chernykh ER,Leplina OY,Sentyakova TN,Demin AA,Kozlov VA

    更新日期:2004-01-01 00:00:00

  • Factors associated with increased white matter hyperintense lesion (WMHI) load in patients with systemic lupus erythematosus (SLE).

    abstract::Introduction White matter hyperintense (WMHI) lesions are the most common finding in magnetic resonance imaging (MRI) of the brain in patients with systemic lupus erythematosus (SLE). Objective The objective of this article is to determine the clinical factors associated with an increase in WMHI lesion load among SLE ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317707062

    authors: Shaharir SS,Osman SS,Md Rani SA,Sakthiswary R,Said MSM

    更新日期:2018-01-01 00:00:00

  • Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.

    abstract::Objectives The aim of this study was to study the relationship between immunosuppressive drug treatment and survival in patients with systemic lupus erythematosus (SLE). Methods Patients who fulfilled four or more American College of Rheumatology criteria for SLE were followed longitudinally. Clinical characteristics,...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317739129

    authors: Mok CC,Tse SM,Chan KL,Ho LY

    更新日期:2018-04-01 00:00:00

  • Unilateral facial erythematous patch as the presenting sign of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that can have many cutaneous manifestations including malar rash, discoid rash or oral ulcer. Isolated unilateral involvement of face is uncommon in SLE. It lacks typical clinical features of LE, and may impose a diagnostic challenge for clinicians. H...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320957739

    authors: Ha DL,Lee GW,Shin K,Kim HS,Ko HC,Kim BS,Kim MB

    更新日期:2020-12-01 00:00:00

  • Clinical trial design in systemic lupus erythematosus: lessons learned and future directions.

    abstract::Designing successful randomized controlled trials (RCTs) in systemic lupus erythematosus (SLE) poses many challenges. It remains difficult to correlate alterations in biologic markers with clinical outcome, especially when signs and symptoms are intermittent and broadly variable between patients. Disease activity indi...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu1034oa

    authors: Strand V

    更新日期:2004-01-01 00:00:00

  • The blood-brain barrier in systemic lupus erythematosus.

    abstract::Central nervous system (CNS) involvement may occur in 20-70% of systemic lupus erythematosus (SLE) patients where neurological symptoms are overt; this is termed neuropsychiatric lupus or NPSLE. This review summarizes evidence that damage to the brain endothelium forming the blood-brain barrier (BBB) is a contributory...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu501oa

    authors: Abbott NJ,Mendonça LL,Dolman DE

    更新日期:2003-01-01 00:00:00

  • Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry.

    abstract:BACKGROUND:Although the survival rate has considerably improved, many patients with systemic lupus erythematosus (SLE) develop irreversible organ damage. OBJECTIVES:The objectives of this paper are to characterize cumulative damage in SLE patients and identify variables associated with its presence and severity. METH...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314555172

    authors: Gonçalves MJ,Sousa S,Inês LS,Duarte C,Borges J,Silva C,Romão VC,Terroso G,Bernardes M,Cerqueira M,Raposo A,Sequeira G,Barcelos A,Macieira C,Canas da Silva J,Costa L,Pereira da Silva JA,Cunha-Miranda L,Da Silva JA,Ca

    更新日期:2015-03-01 00:00:00

  • Aberrant regulation of the integrin very late antigen-4 in systemic lupus erythematosus.

    abstract::Integrin very late antigen-4 (VLA4) is induced during inflammation and can regulate monocyte migration. It has been implicated in atherogenesis, a significant concern in systemic lupus erythematosus (SLE). The aim of this study was to define VLA4 expression in SLE monocytes. Flow cytometry, reverse transcription polym...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313475691

    authors: Rahimi H,Maurer K,Song L,Akhter E,Petri M,Sullivan KE

    更新日期:2013-03-01 00:00:00

  • Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.

    abstract::Peripheral T cell apoptosis is upregulated in active SLE, in parallel with high expression of both membrane-bound and soluble (s) Fas. Previous studies postulated that sFas down-regulates apoptosis in vitro through its blockade of the Fas-L of cytotoxic cells. We have investigated the extent of apoptosis and sFas leve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu250oa

    authors: Silvestris F,Grinello D,Tucci M,Cafforio P,Dammacco F

    更新日期:2003-01-01 00:00:00

  • Mycophenolate mofetil in lupus nephritis.

    abstract::There is an increasing body of literature suggesting the efficacy and tolerability of mycophenolate mofetil (MMF) for the treatment of lupus nephritis. The rationale for its use is based upon its successful profile as an immunosuppressive agent for prevention of allograft rejection, as well as studies in murine models...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2061oa

    authors: Ginzler EM,Aranow C

    更新日期:2005-01-01 00:00:00

  • Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in juvenile systemic lupus erythematosus.

    abstract::Dysregulated neutrophil apoptosis may result in the development of autoimmune disease by contributing to nuclear autoantigen exposure, leading to autoantibody generation and a breakdown in immune tolerance. It has previously been shown that neutrophil apoptosis is increased in juvenile-onset systemic lupus erythematos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203310382128

    authors: Midgley A,Mayer K,Edwards SW,Beresford MW

    更新日期:2011-01-01 00:00:00

  • Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia and seizure.

    abstract::The complement system contributes to the pathogenesis of systemic lupus erythematosus (SLE). Mannose-binding lectin (MBL) is a key molecule of the lectin pathway of complement and seems to be related to the clinical manifestations of this disease. We evaluated the serum levels of MBL and its relationship with disease ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317722846

    authors: Cieslinski JZ,Skare TL,Nisihara R,De Messias-Reason IJ,Utiyama SRR

    更新日期:2018-03-01 00:00:00

  • Spot urine protein/creatinine ratio is unreliable estimate of 24 h proteinuria in lupus nephritis when the histological scores of activity index are higher.

    abstract:OBJECTIVES:The aim of this study was to evaluate the correlation and agreement of spot urine protein/creatinine (P/C) ratio with 24 h proteinuria in patients with lupus nephritis (LN) under different scores of activity index (AI). METHODS:In total, 90 pairs of 24 h urine and spot urine samples from 90 patients with bi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315570688

    authors: Zhang Q,Sun L,Jin L

    更新日期:2015-08-01 00:00:00

  • Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.

    abstract::The aim of this study was to evaluate traditional risk factors for coronary artery disease (CAD), homocysteine, anti-oxidized low-density lipoprotein (anti-oxLDL), anti-lipoprotein lipase (anti-LPL) and endothelin-1 (ET-1) in patients with primary anti-phospholipid syndrome (APS), furthermore verify possible associati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307081847

    authors: de Souza AW,Silva NP,de Carvalho JF,D'Almeida V,Noguti MA,Sato EI

    更新日期:2007-01-01 00:00:00

  • Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort.

    abstract::Objective Adherence to medication has a major impact on treatment control and success especially in chronic diseases but often remains unrecognized. Besides clinical, socioeconomic, disease-related and treatment-related parameters, general and personal health beliefs, as well as perception of health, can affect adhere...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318785245

    authors: Chehab G,Sauer GM,Richter JG,Brinks R,Willers R,Fischer-Betz R,Winkler-Rohlfing B,Schneider M

    更新日期:2018-09-01 00:00:00

  • Infant perinatal thrombosis and antiphospholipid antibodies: a review.

    abstract::Perinatal thrombosis in infants born to mothers with antiphospholipid antibodies (aPL) is a rare event, but with risk of death or severe sequelae. We analysed 16 infants with such perinatal thrombosis reported in the literature in the last 20 years. Thromboses were arterial (13/16), mostly strokes (8/16). Hydrops feta...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203307079039

    authors: Boffa MC,Lachassinne E

    更新日期:2007-01-01 00:00:00

  • Standardization of lupus anticoagulant. The Lupus Anticoagulant Sensitivity Index (LASI).

    abstract::Results for lupus anticoagulant (LA) are expressed as ratio of patient-to-normal clotting times (LA-ratio) according to the equation LA-ratio = (Patient(Clotting time)/Normal(Clotting time)). However, numerical results vary according to the method used for testing, thus making difficult the between-method and between-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312438114

    authors: Tripodi A,Chantarangkul V,Pengo V

    更新日期:2012-06-01 00:00:00